We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bayer said its experimental drug finerenone delayed the progression of chronic kidney disease (CKD) in patients with type 2 diabetes in a late-stage study. Read More
Gene therapies, including genetically modified CAR-T cell therapies, account for 53 percent of all gene, cell and RNA therapies being developed. Read More
Pfizer’s investigational antiviral for treating COVID-19 at home at the first onset of symptoms could become available by the end of this year, said the company’s CEO Albert Bourla. Read More